Diet therapies are currently under-utilised in optimising clinical outcomes for patients with
active ulcerative colitis (UC). Furthermore, existing dietary therapies are framed by poorly …

Inflammatory bowel disease (IBD) are chronic and relapsing disorders of the gastrointestinal
tract, characterized by dysregulated immune responses to the gut microbiome. The gut …

Background Beyond endoscopic remission, histological remission in ulcerative colitis (UC)
is predictive of clinical outcomes. Intestinal ultrasound (IUS) may offer a noninvasive …

Inflammatory bowel disease (IBD) is an emerging global disease characterised by chronic
inflammation of the gastrointestinal tract. However, IBD is also manifested by several …

Diet therapy for inflammatory bowel disease (IBD) is an international research priority but
guidance for IBD-specific diet trial design is lacking. This review critically evaluates key …

Diet is a modifiable risk factor for disease course and data over the past decade have
emerged to indicate its role in Crohn's disease (CD) and ulcerative colitis (UC). However …

Until recently, diet as a therapeutic tool to treat inflammatory bowel disease (IBD) has not
been proven effective. Nearly a century in the making we are in the grips of a revolution in …

Australasia, encompassing Australia, New Zealand, and Papua New Guinea, has some of
the highest prevalence's of inflammatory bowel disease (IBD) in the world. The way IBD …

Background The rising incidence of inflammatory bowel diseases (IBD), including Crohn's
disease (CD) and ulcerative colitis (UC), specifically in the developing world, suggests an …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by
inflammation and ulceration of the colon and rectum. Diet is an important part of UC …